Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Agensys patents

Patents where

Current Assignee

Name

Agensys

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7485299 Serpentine transmembrane antigens expressed in human cancers and uses thereof	Patent 7485299 was granted and assigned to Agensys on February, 2009 by the United States Patent and Trademark Office.	Agensys	United States Patent and Trademark Office	7485299	February 3, 2009
‌ US Patent 7166714 Serpentine transmembrane antigens expressed in human cancers and uses thereof	Patent 7166714 was granted and assigned to Agensys on January, 2007 by the United States Patent and Trademark Office.	Agensys	United States Patent and Trademark Office	7166714	January 23, 2007
‌ US Patent 7611904 Serpentine transmembrane antigens expressed in human cancers and uses thereof	Patent 7611904 was granted and assigned to Agensys on November, 2009 by the United States Patent and Trademark Office.	Agensys	United States Patent and Trademark Office	7611904	November 3, 2009
‌ US Patent 7053186 Antibodies immunospecific for STEAP1	Patent 7053186 was granted and assigned to Agensys on May, 2006 by the United States Patent and Trademark Office.	Agensys	United States Patent and Trademark Office	7053186	May 30, 2006
‌ US Patent 8053551 Serpentine transmembrane antigens expressed in human cancers and uses therefor	Patent 8053551 was granted and assigned to Agensys on November, 2011 by the United States Patent and Trademark Office.	Agensys	United States Patent and Trademark Office	8053551	November 8, 2011
‌ US Patent 6887975 Peptides derived from STEAP1	Patent 6887975 was granted and assigned to Agensys on May, 2005 by the United States Patent and Trademark Office.	Agensys	United States Patent and Trademark Office	6887975	May 3, 2005
‌ US Patent 7575749 Serpentine transmembrane antigens expressed in human cancers and uses thereof	Patent 7575749 was granted and assigned to Agensys on August, 2009 by the United States Patent and Trademark Office.	Agensys	United States Patent and Trademark Office	7575749	August 18, 2009
‌ US Patent 7642054 Serpentine transmembrane antigens expressed in human cancers and uses thereof	Patent 7642054 was granted and assigned to Agensys on January, 2010 by the United States Patent and Trademark Office.	Agensys	United States Patent and Trademark Office	7642054	January 5, 2010
‌ US Patent 7455991 Serpentine transmembrane antigens expressed in human cancers and uses thereof	Patent 7455991 was granted and assigned to Agensys on November, 2008 by the United States Patent and Trademark Office.	Agensys	United States Patent and Trademark Office	7455991	November 25, 2008
‌ US Patent 7968307 Serpentine transmembrane antigens expressed in human cancers and uses thereof	Patent 7968307 was granted and assigned to Agensys on June, 2011 by the United States Patent and Trademark Office.	Agensys	United States Patent and Trademark Office	7968307	June 28, 2011
‌ US Patent 7928201 Serpentine transmembrane antigens expressed in human cancers and uses thereof	Patent 7928201 was granted and assigned to Agensys on April, 2011 by the United States Patent and Trademark Office.	Agensys	United States Patent and Trademark Office	7928201	April 19, 2011
‌ US Patent 8241626 Serpentine transmembrane antigens expressed in human cancers and uses thereof	Patent 8241626 was granted and assigned to Agensys on August, 2012 by the United States Patent and Trademark Office.	Agensys	United States Patent and Trademark Office	8241626	August 14, 2012
‌ US Patent 7427399 Antibodies and related molecules that bind to 161P2F10B proteins	Patent 7427399 was granted and assigned to Agensys on September, 2008 by the United States Patent and Trademark Office.	Agensys	United States Patent and Trademark Office	7427399	September 23, 2008
‌ US Patent 7811565 Antibodies and related molecules that bind to 161P2F10B proteins	Patent 7811565 was granted and assigned to Agensys on October, 2010 by the United States Patent and Trademark Office.	Agensys	United States Patent and Trademark Office	7811565	October 12, 2010
‌ US Patent 9023605 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins	Patent 9023605 was granted and assigned to Agensys on May, 2015 by the United States Patent and Trademark Office.	Agensys	United States Patent and Trademark Office	9023605	May 5, 2015
‌ US Patent 8008442 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins	Patent 8008442 was granted and assigned to Agensys on August, 2011 by the United States Patent and Trademark Office.	Agensys	United States Patent and Trademark Office	8008442	August 30, 2011
‌ US Patent 7361338 Methods to inhibit growth of prostate cancer cells	Patent 7361338 was granted and assigned to Agensys on April, 2008 by the United States Patent and Trademark Office.	Agensys	United States Patent and Trademark Office	7361338	April 22, 2008
‌ US Patent 7947459 Serpentine transmembrane antigens expressed in human cancers and uses thereof	Patent 7947459 was granted and assigned to Agensys on May, 2011 by the United States Patent and Trademark Office.	Agensys	United States Patent and Trademark Office	7947459	May 24, 2011
‌ US Patent 8013135 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins	Patent 8013135 was granted and assigned to Agensys on September, 2011 by the United States Patent and Trademark Office.	Agensys	United States Patent and Trademark Office	8013135	September 6, 2011
‌ US Patent 7795391 Protein showing enhanced expression in cancer cells	Patent 7795391 was granted and assigned to Agensys on September, 2010 by the United States Patent and Trademark Office.	Agensys	United States Patent and Trademark Office	7795391	September 14, 2010
‌ US Patent 8013128 Antibodies and related molecules that bind to PSCA proteins	Patent 8013128 was granted and assigned to Agensys on September, 2011 by the United States Patent and Trademark Office.	Agensys	United States Patent and Trademark Office	8013128	September 6, 2011
‌ US Patent 7595379 Antibodies and related molecules that bind to PSCA proteins	Patent 7595379 was granted and assigned to Agensys on September, 2009 by the United States Patent and Trademark Office.	Agensys	United States Patent and Trademark Office	7595379	September 29, 2009
‌ US Patent 7449548 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer	Patent 7449548 was granted and assigned to Agensys on November, 2008 by the United States Patent and Trademark Office.	Agensys	United States Patent and Trademark Office	7449548	November 11, 2008
‌ US Patent 7884179 Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer	Patent 7884179 was granted and assigned to Agensys on February, 2011 by the United States Patent and Trademark Office.	Agensys	United States Patent and Trademark Office	7884179	February 8, 2011
‌ US Patent 7541442 Antibodies and related molecules that bind to PSCA proteins	Patent 7541442 was granted and assigned to Agensys on June, 2009 by the United States Patent and Trademark Office.	Agensys	United States Patent and Trademark Office	7541442	June 2, 2009

...

Results per page:

170 results

0 selected

170 results

0 selected